IL88513A - D5-1-]) 2-benzyl-3,4-dihydro-H-2 benzopyran-6-yl (methyl [thiazolidine-2,4-deion as a medicinal preparation against atherosclerosis - Google Patents

D5-1-]) 2-benzyl-3,4-dihydro-H-2 benzopyran-6-yl (methyl [thiazolidine-2,4-deion as a medicinal preparation against atherosclerosis

Info

Publication number
IL88513A
IL88513A IL8851388A IL8851388A IL88513A IL 88513 A IL88513 A IL 88513A IL 8851388 A IL8851388 A IL 8851388A IL 8851388 A IL8851388 A IL 8851388A IL 88513 A IL88513 A IL 88513A
Authority
IL
Israel
Prior art keywords
compound
formula
dione
thiazolidine
pharmaceutically acceptable
Prior art date
Application number
IL8851388A
Other languages
English (en)
Hebrew (he)
Other versions
IL88513A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL88513A0 publication Critical patent/IL88513A0/xx
Publication of IL88513A publication Critical patent/IL88513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL8851388A 1987-12-02 1988-11-28 D5-1-]) 2-benzyl-3,4-dihydro-H-2 benzopyran-6-yl (methyl [thiazolidine-2,4-deion as a medicinal preparation against atherosclerosis IL88513A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/127,858 US4798835A (en) 1987-12-02 1987-12-02 dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent

Publications (2)

Publication Number Publication Date
IL88513A0 IL88513A0 (en) 1989-06-30
IL88513A true IL88513A (en) 1994-04-12

Family

ID=22432331

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8851388A IL88513A (en) 1987-12-02 1988-11-28 D5-1-]) 2-benzyl-3,4-dihydro-H-2 benzopyran-6-yl (methyl [thiazolidine-2,4-deion as a medicinal preparation against atherosclerosis

Country Status (16)

Country Link
US (1) US4798835A (ko)
EP (1) EP0319288B1 (ko)
JP (1) JPH01186883A (ko)
KR (1) KR900006993B1 (ko)
AT (1) ATE81456T1 (ko)
AU (1) AU604176B2 (ko)
CA (1) CA1313139C (ko)
DE (1) DE3875324T2 (ko)
DK (1) DK670988A (ko)
HU (1) HU204433B (ko)
IE (1) IE883600L (ko)
IL (1) IL88513A (ko)
MY (1) MY103498A (ko)
PH (1) PH24873A (ko)
PT (1) PT89123B (ko)
ZA (1) ZA888968B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
EP0715853A1 (en) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Use of glutathione esters for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5306724A (en) * 1992-08-17 1994-04-26 Clintec Nutrition Company Method for preventing and treating atherosclerosis
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
GB9611947D0 (en) * 1996-06-07 1996-08-07 Glaxo Group Ltd Medicaments

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物

Also Published As

Publication number Publication date
DE3875324T2 (de) 1993-02-25
PT89123B (pt) 1993-09-30
PH24873A (en) 1990-12-26
DE3875324D1 (de) 1992-11-19
EP0319288A3 (en) 1990-12-27
DK670988D0 (da) 1988-12-01
ATE81456T1 (de) 1992-10-15
AU604176B2 (en) 1990-12-06
KR890009922A (ko) 1989-08-04
HU204433B (en) 1992-01-28
KR900006993B1 (ko) 1990-09-25
AU2647188A (en) 1989-06-08
CA1313139C (en) 1993-01-26
PT89123A (pt) 1989-12-29
JPH0460582B2 (ko) 1992-09-28
IE883600L (en) 1989-06-02
ZA888968B (en) 1990-07-25
HUT54045A (en) 1991-01-28
EP0319288A2 (en) 1989-06-07
IL88513A0 (en) 1989-06-30
DK670988A (da) 1989-07-24
US4798835A (en) 1989-01-17
EP0319288B1 (en) 1992-10-14
MY103498A (en) 1993-06-30
JPH01186883A (ja) 1989-07-26

Similar Documents

Publication Publication Date Title
JP2004210797A (ja) アムロジピン及びアトルバスタチンを含む治療用の組み合わせ
HU220669B1 (hu) Eljárás diabéteszes szövődmények kezelésére vagy megelőzésére szolgáló gyógyászati készítmények előállítására
EP0319288B1 (en) dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
CN1092517C (zh) 利用2,6－二烷基－4－甲硅烷基－苯酚降低血清胆固醇水平的方法
FR2590170A1 (fr) Agents therapeutiques a base de sel d'acyloxyalcanoylcholine, apportant une amelioration dans le traitement de la demence
US5739159A (en) Medicaments for the treatment of cardiac insufficiency
US20040009986A1 (en) Triglyceride depressant composition
US5480891A (en) Method for treating diabetes mellitus
US5391551A (en) Method of lowering blood lipid levels
US6998422B2 (en) Lipid peroxide-lowering compositions
US5175179A (en) Method for treating hypertension
EP0469837B1 (en) Use of a compound in the manufactur of a medicament for lowering of blood uric acid levels
US6479676B1 (en) OxiranEcarboxylic acids for the treatment of diabetes
US4847255A (en) Cyclopentyl ethers and their use in medicine
AU651873B2 (en) Method of inhibiting the progressive development of diabetes mellitus
US4978667A (en) Substituted 6H-7,8-dihydrothiapyrano(3,2-d)-pyrimidines as hypoglycemic agents
EP0248999A2 (en) Uses of enprostil-type prostaglandins in regulating fat and carbohydrate metabolism
KR920003579B1 (ko) 혈중 지질 조성을 개선시키기 위한 제약 조성물